{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:49:11Z","timestamp":1775260151060,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"value":"9781071648476","type":"print"},{"value":"9781071648483","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4848-3_18","type":"book-chapter","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:14:04Z","timestamp":1762164844000},"page":"275-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ELISPOT-Based Measurement of Antibody-Secreting Cells and Memory B Cells Specific to Trypanosoma cruzi in Chronically Infected Subjects"],"prefix":"10.1007","author":[{"given":"Gonzalo Leandro","family":"Cesar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Gabriela","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana Adriana","family":"Laucella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cecilia","family":"Albareda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1056\/NEJM200011093431908","volume":"343","author":"AM Feldman","year":"2000","unstructured":"Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388\u20131398. https:\/\/doi.org\/10.1056\/NEJM200011093431908","journal-title":"N Engl J Med"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","volume":"115","author":"GA Schmunis","year":"2010","unstructured":"Schmunis GA, Yadon ZE (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115:14\u201321. https:\/\/doi.org\/10.1016\/j.actatropica.2009.11.003","journal-title":"Acta Trop"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/s0074-02762002000100001","volume":"97","author":"JR Coura","year":"2002","unstructured":"Coura JR, Castro SLD (2002) A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97:3\u201324. https:\/\/doi.org\/10.1590\/s0074-02762002000100001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/AAC.01662-13","volume":"58","author":"R Viotti","year":"2014","unstructured":"Viotti R, Alarc\u00f3n De Noya B, Araujo-Jorge T et al (2014) Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother 58:635\u2013639. https:\/\/doi.org\/10.1128\/AAC.01662-13","journal-title":"Antimicrob Agents Chemother"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","volume":"144","author":"R Viotti","year":"2006","unstructured":"Viotti R, Vigliano C, Lococo B et al (2006) Long-term cardiac outcomes of treating chronic Chagas disease with Benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144:724\u2013734. https:\/\/doi.org\/10.7326\/0003-4819-144-10-200605160-00006","journal-title":"Ann Intern Med"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s0037-86822007000100001","volume":"40","author":"DL Fabbro","year":"2007","unstructured":"Fabbro DL, Streiger ML, Arias ED et al (2007) Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Rev Soc Bras Med Trop 40:1\u201310. https:\/\/doi.org\/10.1590\/s0037-86822007000100001","journal-title":"Rev Soc Bras Med Trop"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/CVI.00106-07","volume":"15","author":"O S\u00e1nchez Negrette","year":"2008","unstructured":"S\u00e1nchez Negrette O, S\u00e1nchez Vald\u00e9z FJ, Lacunza CD et al (2008) Serological evaluation of specific-antibody levels in patients treated for chronic Chagas\u2019 disease. Clin Vaccine Immunol 15:297\u2013302. https:\/\/doi.org\/10.1128\/CVI.00106-07","journal-title":"Clin Vaccine Immunol"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/14787210.7.2.1579","volume":"7","author":"R Viotti","year":"2009","unstructured":"Viotti R, Vigliano C, Lococo B et al (2009) Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Rev Anti-Infect Ther 7:157\u2013163. https:\/\/doi.org\/10.1586\/14787210.7.2.1579","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1128\/AAC.01401-12","volume":"57","author":"MJ Pinazo","year":"2013","unstructured":"Pinazo MJ, Guerrero L, Posada E et al (2013) Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic Chagas disease. Antimicrob Agents Chemother 57:390\u2013395. https:\/\/doi.org\/10.1128\/AAC.01401-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"18_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008067","volume":"14","author":"E Sulleiro","year":"2020","unstructured":"Sulleiro E, Silgado A, Serre-Delcor N et al (2020) Usefulness of real-time PCR during follow-up of patients treated with Benznidazole for chronic Chagas disease: experience in two referral centers in Barcelona. PLoS Negl Trop Dis 14(2):e0008067. https:\/\/doi.org\/10.1371\/journal.pntd.0008067","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"18_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001314","volume":"5","author":"R Viotti","year":"2011","unstructured":"Viotti R, Vigliano C, \u00c1lvarez MG et al (2011) Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis 5(9):e1314. https:\/\/doi.org\/10.1371\/journal.pntd.0001314","journal-title":"PLoS Negl Trop Dis"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna IJ, Carlson NE, Slifka MK (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357:1903\u20131915. https:\/\/doi.org\/10.1056\/NEJMoa066092","journal-title":"N Engl J Med"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature07231","volume":"455","author":"X Yu","year":"2008","unstructured":"Yu X, Tsibane T, McGraw PA et al (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455:532\u2013536. https:\/\/doi.org\/10.1038\/nature07231","journal-title":"Nature"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt SL, Hodgkin PD, Tarlinton DM et al (2015) The generation of antibody-secreting plasma cells. Nat Rev Immunol 15:160\u2013171. https:\/\/doi.org\/10.1038\/nri3795","journal-title":"Nat Rev Immunol"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/TP.0000000000002594","volume":"103","author":"L Ionescu","year":"2019","unstructured":"Ionescu L, Urschel S (2019) Memory B cells and long-lived plasma cells. Transplantation 103:890\u2013898. https:\/\/doi.org\/10.1097\/TP.0000000000002594","journal-title":"Transplantation"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/jac\/dkab054","volume":"76","author":"MD Castro Eiro","year":"2021","unstructured":"Castro Eiro MD, Natale MA, Alvarez MG et al (2021) Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease. J Antimicrob Chemother 76:1580\u20131592. https:\/\/doi.org\/10.1093\/jac\/dkab054","journal-title":"J Antimicrob Chemother"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/infdis\/jiac495","volume":"227","author":"G Cesar","year":"2023","unstructured":"Cesar G, Natale MA, Albareda MC et al (2023) B-cell responses in chronic chagas disease: waning of Trypanosoma cruzi-specific antibody-secreting cells following successful etiological treatment. J Infect Dis 227:1322\u20131332. https:\/\/doi.org\/10.1093\/infdis\/jiac495","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"18_CR18","first-page":"82","volume":"53","author":"EN Cura","year":"1993","unstructured":"Cura EN, Ruiz AM, Vel\u00e1zquez E et al (1993) Estandarizaci\u00f3n de un kit de confirmaci\u00f3n (Fatala Kit) para el immunodiagn\u00f3stico para infecci\u00f3n para Trypanosoma cruzi. Medicina (B Aires) 53(Suppl 1):82","journal-title":"Medicina (B Aires)"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4939-9148-8_25","volume":"1955","author":"MC Albareda","year":"2019","unstructured":"Albareda MC, Natale MA, Cesar GL et al (2019) Trypanosoma cruzi-specific T-cell responses to monitor treatment efficacy in chronic Chagas disease. Methods Mol Biol 1955:339\u2013348. https:\/\/doi.org\/10.1007\/978-1-4939-9148-8_25","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","T. cruzi Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4848-3_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:31:24Z","timestamp":1775255484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4848-3_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"ISBN":["9781071648476","9781071648483"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4848-3_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"4 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}